CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 46 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $324,097 | -17.5% | 8,757 | -6.4% | 0.00% | -50.0% |
Q1 2024 | $392,671 | -54.0% | 9,356 | -56.6% | 0.00% | 0.0% |
Q4 2023 | $854,118 | +74.8% | 21,536 | +21.3% | 0.00% | 0.0% |
Q3 2023 | $488,645 | -54.1% | 17,756 | -43.4% | 0.00% | -33.3% |
Q2 2023 | $1,064,214 | +47.0% | 31,365 | +55.9% | 0.00% | 0.0% |
Q1 2023 | $724,062 | +131.8% | 20,124 | +187.2% | 0.00% | +200.0% |
Q4 2022 | $312,347 | -19.5% | 7,008 | -49.2% | 0.00% | 0.0% |
Q3 2022 | $388,000 | -49.2% | 13,789 | -51.3% | 0.00% | 0.0% |
Q2 2022 | $764,000 | +13.4% | 28,320 | +43.2% | 0.00% | 0.0% |
Q1 2022 | $674,000 | -61.4% | 19,776 | -56.3% | 0.00% | 0.0% |
Q4 2021 | $1,747,000 | +18.8% | 45,208 | +65.9% | 0.00% | -50.0% |
Q3 2021 | $1,471,000 | +67.3% | 27,251 | +3.7% | 0.00% | +100.0% |
Q2 2021 | $879,000 | -48.4% | 26,283 | -68.2% | 0.00% | -66.7% |
Q1 2021 | $1,702,000 | +302.4% | 82,637 | +242.1% | 0.00% | +200.0% |
Q4 2020 | $423,000 | +2388.2% | 24,159 | +140.0% | 0.00% | – |
Q1 2020 | $17,000 | -29.2% | 10,065 | -7.4% | 0.00% | – |
Q4 2019 | $24,000 | -36.8% | 10,870 | -39.1% | 0.00% | – |
Q3 2019 | $38,000 | +100.0% | 17,837 | +157.1% | 0.00% | – |
Q2 2019 | $19,000 | -64.8% | 6,937 | -36.6% | 0.00% | -100.0% |
Q1 2019 | $54,000 | – | 10,948 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,388,967 | $125,425,669 | 9.68% |
5AM Venture Management, LLC | 497,270 | $18,403,963 | 4.12% |
COMMODORE CAPITAL LP | 1,425,000 | $52,739,250 | 3.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 374,910 | $13,875,419 | 3.27% |
TSP Capital Management Group, LLC | 249,220 | $9,223,635 | 2.89% |
Eventide Asset Management | 3,327,132 | $123,137,155 | 2.11% |
Affinity Asset Advisors, LLC | 475,400 | $17,594,554 | 2.03% |
Novo Holdings A/S | 850,000 | $31,458,500 | 1.83% |
Bellevue Group AG | 2,971,615 | $109,979,471 | 1.79% |
Redmile Group, LLC | 718,723 | $26,599,938 | 1.61% |